Corcept Therapeutics (CORT) Tops Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $117.51 --0%
Revenue Growth %: +56.0%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
NEOV, MANU, CTAS, More
Revenue Growth %: +56.0%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
NEOV, MANU, CTAS, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q3 EPS of $0.31, $0.11 better than the analyst estimate of $0.20. Revenue for the quarter came in at $81.5 million versus the consensus estimate of $78 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- UBS Upgrades Bajaj Finance Ltd. (BAF:IN) to Neutral
- Societe Generale SA (GLE:FP) (SCGLY) PT Raised to EUR83 at JPMorgan
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
